Clinical Trial

Clinical Trial of MED HF10™ Spinal Cord Stimulation for the Treatment of Chronic Pain

Study acronym: MED
Active, Not Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
This is a single-center, prospective, non-randomized exploratory study in subjects with chronic, intractable back pain and/or leg pain per the center's routine practice. The primary endpoint is the distribution of responders by 'lowest preferred pulse dose (PD)' setting, where a subject is a responder to the lowest PD setting they preferred prior to entering the Observational period. The study is performed in patients who already have Nevro SCS devices implanted.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-03-20.
Trial Details
NCT Number NCT06897280
Lead Sponsor Nevro Corp
Conditions Chronic, Intractable Back Pain and/or Leg Pain
Enrollment 25 participants
Start Date 2021-11-16
Primary Completion 2024-11-16 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2026-06-29